Title: A Novel Nanotechnology for Psychiatric Disorders: A Multicultural Nanoprobe for Amyloidosis of the Skin in Patients with Body Dysmorphic Disorder

Abstract:

The superstar, Robin Williams, had a long documented history of clinical depression that has been shown to be empirically associated with the disorder of Parkinson. Nonetheless, it was later found during his autopsy that the neurotransmitter, dopamine,was missing, Actually, half of the biomarker, dopamine, was missing in the motor neurons in the brain of the beloved Robin Williams. Moreover, Lewy bodies were found! Lewy bodies contain the molecules that cause depression and it so happens that these Lewy bodies contain the molecules that lead to not only depression but also neurodegenerative disorders such as Alzheimer disease. Let’s look at this carefully. The discoveries made for our Robin, our star, were  post-mortem, that is, after death. One woman is looking to change all this. Patricia Broderick has found a way to see inside the brain of the Parkinson patient LIVE! In fact, she has discovered the Tau Peptide, responsible for Alzheimer and Parkinson and she has made this discovery LIVE! Eazysense Nanotechnologies Inc.is the start-up company that has successfully manufactured the tiny probe, smaller than a human hair, for the human and the animal patient. The nanoprobe is named after her father, Paddy Broderick. The BRODERICK PROBE^® senses the neurotransmitters as the subject walks. The nanoprobe sensors also see inside the brain of depression and bipolar diseases easily. Our new photodiode nanoprobe sensor is poised to revolutionize the industry. The nanosensor is comprised of carbon polymers and proteins from the opsin family that provide a new voltaic optical sensor. The polymeic carbon allotrope, fullerene, is, indeed, a semiconductor. In proud association with the Technology Commercialization Office, CUNY, the Reaearch Foundation of CUNY and its patent lawyers, Dr. Broderick has achieved the value of the Eazysense start-up company at the billion dollar acquisition level. The Broderick Brain Foundation is the non-profit arm of Eazysense Nanotechnologies Inc, in NY and is available worldwide for service. The Foundation is a 501 (c) (3) NY State Tax Exempt Organization. Support for this organization is tax-deductible to the extent of the law.

Biography:

Patricia A. Broderick has completed her PhD from St John’s University, Queens, NY, USA and her postdoctoral studies from The Albert Einstein Medical Center, Bronx, NY, USA and Cornell University Medical School, White Plains, NY, USA. Patricia serves as Tenured and Full Medical Professor in the Dept. of Molecular, Cellular and Biomedical Sciences at the City University of New York School of Medicine and as Director of the Neurobiology Course at the Sophie Davis School of Biomedical Education, CUNY School of Medicine, CCNY. A highly recognized expert and prominent editor, author, inventor and lecturer, Patricia has published more than 500 papers in reputed journals and sought after books and she serves as an editorial board member of repute worldwide. Dr. Broderick holds several patents and trademarks and is the Founder and CEO of Eazysense Nanotechnologies Inc.and the Broderick Brain Foundation